February 24, 2022 Comments Off on New patent for Biofrontera drug AMELUZ Posted in: Patent Added Annual Drug Patent Expirations for AMELUZ Ameluz is a drug marketed by Biofrontera and is included in one NDA. It is available from one supplier. The generic ingredient in AMELUZ…
The post New patent for Biofrontera drug AMELUZ appeared first on DrugPa…
February 23, 2022 Comments Off on New patent for Otsuka drug ABILIFY MYCITE KIT Posted in: Patent Added Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one…
The post New patent for Otsuka drug ABILIFY MYCITE KIT appeared f…